These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6342552)

  • 1. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
    Leino R; Vuento R; Koskimies S; Viander M; Toivanen A
    Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in yersinia-associated reactive arthritis.
    Aho K; Ahvonen P; Juvakoski T; Kousa M; Leirisalo M; Laitinen O
    Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection.
    Vuento R; Leino R; Viander M; Toivanen A
    Clin Exp Rheumatol; 1983; 1(3):219-24. PubMed ID: 6398162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
    Repo H; Leirisalo-Repo M
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD; Asmussen JU
    Z Rheumatol; 1993; 52(4):210-4. PubMed ID: 8212919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis.
    Hermann E; Fleischer B; Mayet WJ; Poralla T; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1989 Mar; 75(3):365-70. PubMed ID: 2467775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
    Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.
    Merilahti-Palo R; Söderström KO; Lahesmaa-Rantala R; Granfors K; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):87-90. PubMed ID: 1998396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R; Eskola J; Leino R; Koskimies S; Viander M
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia antibodies in inflammatory joint diseases.
    Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
    Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte transformation responses to gram negative bacteria after Yersinia and Salmonella infection: the importance of enterobacterial common antigen for the response.
    Vuento R; Leino R; Viander M; Toivanen A
    J Rheumatol; 1984 Jun; 11(3):369-72. PubMed ID: 6376802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cell-mediated immunity among HLA-B27 related rheumatoid variants responding to Yersinia antigen.
    Goebel KM; Goebel FD; Baier R
    J Clin Lab Immunol; 1982 Jun; 8(2):75-81. PubMed ID: 6213777
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection.
    Nickerson CL; Luthra HS; Savarirayan S; David CS
    Hum Immunol; 1990 Aug; 28(4):382-96. PubMed ID: 2391253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.
    Toivanen A; Granfors K; Lahesmaa-Rantala R; Leino R; Ståhlberg T; Vuento R
    Immunol Rev; 1985 Aug; 86():47-70. PubMed ID: 3930389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitization of Yersinia arthropathy patients to HLA-B27 antigen].
    Zotikov EA; Sidel'nikova SM; Kut'ina RM
    Revmatologiia (Mosk); 1985; (3):56-8. PubMed ID: 3903935
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen-specific lymphocyte transformation in patients with recent yersiniosis.
    Vuento R
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):89-93. PubMed ID: 6192678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia arthritis in the Midlands: clinical and immunological features in ten cases during 1980-1983.
    Sheldon PJ; Pell P
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):46-9. PubMed ID: 6606474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.